The number of shares and votes in Vimian Group AB (publ) (“Vimian”) changed during July as a result of (i) share subscriptions through the exercise of warrants as part of the warrant program adopted by Vimian’s Annual General Meeting on 2 June 2023, (ii) the issue of D shares, E1 2026 shares and E2 2026 shares as part of Vimian’s incentive program LTIP 2026/2029, and (iii) redemption of E1 2025, E2 2025 and E3 2025 shares.
Today, the last trading day of the month, there are a total of 533,065,851 shares in Vimian. 527,139,763 shares are ordinary shares with one vote per share. 938,605 shares are C shares, 3,206,706 shares are D shares, 276,290 shares are E1 2025 shares, 276,297 shares are E2 2025 shares, 276,300 shares are E3 2025 shares, 475,945 shares are E1 2026 shares and 475,945 shares are E2 2026 shares, each with one-tenth of a vote per share. The total number of votes in Vimian is 527,732,371.8.
For further information, please contact:
Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 73 626 88 86
About Vimian
Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches veterinary clinics and laboratories in over 80 markets, has 1,300 employees and annual revenues of approximately EUR 425 million. For more information, please visit: www.vimian.com.
This information is information that Vimian Group is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-07-31 17:30 CEST.